Peripheral stent startup Veniti Inc. is being acquired by Boston Scientific Corp., its investor and partner, for up to $160 million. Once complete, this will be the seventh acquisition by the Marlborough, Mass.-based medical device company has made so far this year – a pace that far outstrips its typical rate of two or three purchases per year. Read More
